As expected, the proportion of tumor area positive for CD68 was significantly higher in OGC-IC NST than in Ctl-IC NST (mean: 10.1% vs. 0.9%, p < 0.001), and in OGC-MC compared to Ctl-MC (mean: 13.1% vs. 1.7%, p = 0.032) (Fig. 2G). This evidence concerns the gene CD68 and neoplasm.